BACKGROUND: In acquired heart disease, brain natriuretic peptide (BNP) and N-Terminal pro-brain natriuretic peptide (NT-proBNP) are increasingly used as diagnostic and prognostic markers. In adult congenital heart disease, the abnormal anatomy and physiology complicate assessment of cardiac function. We studied the clinical correlates of measurement of natriuretic peptides (NP) in adults with a right ventricle in the systemic position or with Fontan-type physiology. METHODS: A prospective longitudinal study (follow up time 23+/-13 months, mean+/-S.D.) was conducted in a specialised centre on 61 patients (age 26+/-8 years; NYHA class 1.5+/-0.6) including Senning/Mustard corrected transposition, congenitally corrected transposition and Fontan/total cavopulmonary connection. Plasma NP concentration was compared with NYHA class, exercise capacity and echocardiographically determined systemic systolic ventricular function. RESULTS: Neurohormone concentrations were generally elevated (mean=290% of upper reference limit) and related to NYHA class (P<0.001, NYHA I vs. II-IV). No clinically significant relationship to ventricular function or exercise capacity was found however. An NP measurement could not predict the future course of the disease in terms of functional status or ventricular function. CONCLUSION: In contrast to patients with acquired heart disease, measurement of NP seems to have low clinical value in adults with a right ventricle in the systemic position or with Fontan-type physiology.
BACKGROUND: In acquired heart disease, brain natriuretic peptide (BNP) and N-Terminal pro-brain natriuretic peptide (NT-proBNP) are increasingly used as diagnostic and prognostic markers. In adult congenital heart disease, the abnormal anatomy and physiology complicate assessment of cardiac function. We studied the clinical correlates of measurement of natriuretic peptides (NP) in adults with a right ventricle in the systemic position or with Fontan-type physiology. METHODS: A prospective longitudinal study (follow up time 23+/-13 months, mean+/-S.D.) was conducted in a specialised centre on 61 patients (age 26+/-8 years; NYHA class 1.5+/-0.6) including Senning/Mustard corrected transposition, congenitally corrected transposition and Fontan/total cavopulmonary connection. Plasma NP concentration was compared with NYHA class, exercise capacity and echocardiographically determined systemic systolic ventricular function. RESULTS: Neurohormone concentrations were generally elevated (mean=290% of upper reference limit) and related to NYHA class (P<0.001, NYHA I vs. II-IV). No clinically significant relationship to ventricular function or exercise capacity was found however. An NP measurement could not predict the future course of the disease in terms of functional status or ventricular function. CONCLUSION: In contrast to patients with acquired heart disease, measurement of NP seems to have low clinical value in adults with a right ventricle in the systemic position or with Fontan-type physiology.
Authors: Werner Budts; Jolien Roos-Hesselink; Tanja Rädle-Hurst; Andreas Eicken; Theresa A McDonagh; Ekaterini Lambrinou; Maria G Crespo-Leiro; Fiona Walker; Alexandra A Frogoudaki Journal: Eur Heart J Date: 2016-01-18 Impact factor: 29.983
Authors: Brian W McCrindle; Victor Zak; Lynn A Sleeper; Stephen M Paridon; Steven D Colan; Tal Geva; Lynn Mahony; Jennifer S Li; Roger E Breitbart; Renee Margossian; Richard V Williams; Welton M Gersony; Andrew M Atz Journal: Circulation Date: 2009-12-21 Impact factor: 29.690
Authors: Jonathan Rhodes; Renee Margossian; Lynn A Sleeper; Piers Barker; Timothy J Bradley; Minmin Lu; Mark Fogel; Matthew A Harris; Wyman W Lai; Andrew J Powell; Michael D Puchalski; Girish Shirali; Steven D Colan Journal: J Am Soc Echocardiogr Date: 2011-11 Impact factor: 5.251
Authors: Alexander Lukasz; Gernot Beutel; Philipp Kümpers; Agnieszka Denecke; Mechthild Westhoff-Bleck; Bernhard Schieffer; Johann Bauersachs; Jan T Kielstein; Oktay Tutarel Journal: PLoS One Date: 2013-06-24 Impact factor: 3.240
Authors: Oktay Tutarel; Agnieszka Denecke; Stefanie M Bode-Böger; Jens Martens-Lobenhoffer; Svjetlana Lovric; Johann Bauersachs; Bernhard Schieffer; Mechthild Westhoff-Bleck; Jan T Kielstein Journal: PLoS One Date: 2012-03-21 Impact factor: 3.240
Authors: Olga Trojnarska; Adrian Gwizdała; Sławomir Katarzyński; Agnieszka Katarzyńska; Zofia Oko-Sarnowska; Piotr Bręborowicz; Stefan Grajek Journal: Arch Med Sci Date: 2010-04-30 Impact factor: 3.318
Authors: Marketa Hegarova; Jaroslav Brotanek; Milos Kubanek; Radka Kockova; Janka Franekova; Vera Lanska; Ivan Netuka; Vojtech Melenovsky; Ivan Malek; Josef Kautzner Journal: Croat Med J Date: 2016-08-31 Impact factor: 1.351